Detalhe da pesquisa
1.
Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets.
NPJ Breast Cancer
; 9(1): 97, 2023 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38042915
2.
Stromal NRG1 in luminal breast cancer defines pro-fibrotic and migratory cancer-associated fibroblasts.
Oncogene
; 40(15): 2651-2666, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33692466
3.
Modeling ERBB receptor-regulated G1/S transition to find novel targets for de novo trastuzumab resistance.
BMC Syst Biol
; 3: 1, 2009 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19118495